Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04639973
Other study ID # HSC-MS-20-0895
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date November 21, 2022

Study information

Verified date April 2024
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the feasibility of ultrasound in the first trimester, assess the completion rate of ultrasounds for fetal anatomy in the first trimester compared to completion rates of ultrasounds for fetal anatomy in the second trimester and to assess the completion rate of the combination of one ultrasound in the first trimester and one in the second trimesters compared to the individual completion rates of both evaluations in obese pregnant women.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date November 21, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - BMI greater than or equal to 35 - Presented for ultrasound before 14 weeks at The University of Texas Professional Building, Memorial City, Bellaire, or Lyndon-Baines Johnson clinics - Primary language is English or Spanish - Consent to an extra transvaginal ultrasound if needed - Singleton gestation - No previous anomalies known before consent - Missed abortion (nonviable pregnancy) Exclusion Criteria: - Elective abortion after recruitment - Missed abortion after first trimester ultrasound - Did not receive second trimester ultrasound

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Group 1 (First trimester ultrasound)
A detailed first trimester anatomy ultrasound will be performed,at the visit when the subject is confirmed to be of eligible gestational age. After this detailed research ultrasound, which will be limited to 15 minutes, subject will then receive the clinically indicated dating ultrasound or nuchal translucency measurement. The patient will complete a survey about her satisfaction with this technique via email.as a safety measure, if an anomaly is suspected on the day of the detailed first trimester anatomy scan, the patient will be unblinded. Patients in this arm are later scheduled for a second trimester ultrasound by the clinical team, as this is part of standard obstetrical care.
Group 2 (Second trimester anatomy ultrasound)
Patients do not undergo a detailed first trimester ultrasound , but will receive the clinically indicated limited ultrasound for dating or for nuchal translucency. Patient will then undergoes a second trimester ultrasound by the clinical team as part of standard obstetrical care and completes a survey regarding her satisfaction with this technique via email.

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

References & Publications (2)

Buskmiller C, Fishel Bartal M, Bonilla M, Denham C, Nguyen R, Sibai B, Pedroza C, Hernandez-Andrade E. First trimester anatomy ultrasound for patients with obesity: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023 Nov;5(11):101143. doi: 10.101 — View Citation

Buskmiller C, Toates SE, Rodriguez V, Hernandez-Andrade E. A learning curve for first trimester anatomy ultrasound in obese patients. Gynecol Obstet Invest. 2024 Mar 22. doi: 10.1159/000538477. Online ahead of print. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Completion Rate for First Trimester Scans Completion rate is reported as the number of scans that see all the views divided by total number of scans in that group 12-14 weeks of pregnancy
Primary Completion Rate for Second Trimester Scans Completion rate is reported as the number of scans that see all the views divided by total number of scans. 18-22 weeks of pregnancy
Secondary Completion Rate of First Trimester and Second Trimester Scans This outcome is reported as [(# of completed 1st tri anatomy scans) + (# of completed 2nd tri anatomy scans in women without a completed first tri anatomy scan)]/(total number of women in first trimester group). 12-22 weeks of pregnancy
Secondary Time Taken to Complete Scan in the First Trimester Ultrasound Group 12-14 weeks of pregnancy
Secondary Number of Anomalies Identified in First Trimester Group Scans 12-14 weeks of pregnancy
Secondary Number of Anomalies Identified in Second Trimester Group Scans 12-22 weeks of pregnancy
Secondary Number of Anomalies Missed in First Trimester Group Scans 12-14 weeks of pregnancy
Secondary Number of Anomalies Missed in Second Trimester Group Scans 12-22 weeks of pregnancy
Secondary Number of Participants With Infants Who Survive 9 months from randomization
Secondary Gestational Age at Delivery at the time of delivery (about 40 weeks of pregnancy)
Secondary Number of Participants With Infants Admitted to the Neonatal Intensive Care Unit (NICU) at the time of NICU admission (about 0 to 28 days after birth)
Secondary Hospital Length of Stay from time of hospital admission to discharge (about 0 to 365 days after birth)
Secondary Number of Participants With Infants With Neonatal Morbidities Neonatal morbidities include hypoglycemia 9 months from randomization
Secondary Number of Participants Who Were Very Satisfied With Ultrasound as Measured by the Standardized Survey in the First Trimester Group Scans The survey asks "Overall, how satisfied were you with today's ultrasound?," and participants selected one of the below choices. Number who chose "Very Satisfied" is reported.
Very satisfied
Somewhat satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied
6 months from randomization
Secondary Cost of Intervention Compared to Usual Care cost benefit analysis based on whether more ultrasounds were done in cases of early discovery of anomalies from 12-22 weeks of pregnancy
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2